translational medicine

OncoOmics Lab – Cancer Multi-Omics and Translational Biology

OncoOmics Lab – Cancer Multi-Omics and Translational Biology

Il OncoOmics Lab – Cancer Multi-Omics and Translational Biology si focalizza sull’integrazione di dati genomici, trascrittomici, metabolomici e proteomici per comprendere i meccanismi di resistenza ai trattamenti nei tumori solidi. Il gruppo studia la riprogrammazione metabolica, l’adattamento mitocondriale e il ruolo delle cellule staminali tumorali, con particolare attenzione a prostata e polmone.

Substantial overview on mesenchymal stem cell biological and physical properties as an opportunity in translational medicine

Mesenchymal stem cells (MSC) have piqued worldwide interest for their extensive potential to treat a large array of clinical indications, their unique and controversial immunogenic and immune modulatory properties allowing ample discussions and debates for their possible applications. Emerging data demonstrating that the interaction of biomaterials and physical cues with MSC can guide their differentiation into specific cell lineages also provide new interesting insights for further MSC manipulation in different clinical applications.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma